Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n = 1,090), we observed that spike-specific IgG antibody levels and ACE2 antibody binding inhibition responses elicited by a single vaccine dose in individuals with prior SARS-CoV-2 infection (n = 35) were similar to those seen after...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebinger, Joseph E., Fert-Bober, Justyna, Printsev, Ignat, Wu, Min, Sun, Nancy, Prostko, John C., Frias, Edwin C., Stewart, James L., Van Eyk, Jennifer E., Braun, Jonathan G., Cheng, Susan, Sobhani, Kimia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205849/
https://www.ncbi.nlm.nih.gov/pubmed/33795870
http://dx.doi.org/10.1038/s41591-021-01325-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205849/
https://www.ncbi.nlm.nih.gov/pubmed/33795870
http://dx.doi.org/10.1038/s41591-021-01325-6

Ejemplares similares